Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo


Unsupported browser: Your browser does not meet modern web standards. See how it scores »

{ action.text }

Researchers at the University of California, San Diego, have constructed the first complete computer model of human metabolism. Available free on the Web, the model is a major step forward in the fledging field of systems biology, and it will help researchers uncover new drug pathways and understand the molecular basis of cancer and other diseases.

Metabolism is the sum of all chemical reactions involved in breaking down the nutrients in food into energy and using them as the raw materials for making everything the body needs, from hormones like insulin to the lipids that make up cell membranes. The computer model of metabolism, constructed by researchers in the lab of Bernhard Palsson, professor of bioengineering, connects all such known chemical reactions in the body to every human gene.

Similar models of metabolism in microbes such as yeast and E. coli–including several generated by Palsson’s lab–are enabling researchers to engineer organisms that more efficiently produce products like ethanol and antimalarial drugs. (See “Watching Bacteria Evolve in the Lab” and “Engineered Microbes Boost Ethanol.”) But, says Aviv Regev, a computational biologist at the Broad Institute, in Cambridge, MA, “a high-quality model of metabolism in humans has been elusive.”

The new model includes every known gene and every metabolic reaction Palsson’s group uncovered in an extensive search of the scientific literature. A given gene in the database is associated with its protein product, which might be associated with a number of metabolic reactions, which are associated with other reactions, which are associated with nutritional inputs like glucose and the output of energy or a product like melatonin. Palsson calls the model “a mathematical representation of all this data.” The online database will be updated continuously.

Regev says that one of the model’s most promising applications is as a “scaffold on which to project data” from gene-expression profiling studies. Using microarrays, it is now possible to find differences in gene expression between, for example, normal liver tissue, cancerous liver tissue, and diabetic liver tissue. Such data has the potential to reveal both the molecular causes of disease and potential drug targets. But in these studies, says Regev, “changes in gene expression are spread all over [the genome].”

1 comment. Share your thoughts »

Credit: Jacobs School of Engineering, UC San Diego

Tagged: Biomedicine, cancer, genome, drugs, disease, bacteria, gene expression

Reprints and Permissions | Send feedback to the editor

From the Archives


Introducing MIT Technology Review Insider.

Already a Magazine subscriber?

You're automatically an Insider. It's easy to activate or upgrade your account.

Activate Your Account

Become an Insider

It's the new way to subscribe. Get even more of the tech news, research, and discoveries you crave.

Sign Up

Learn More

Find out why MIT Technology Review Insider is for you and explore your options.

Show Me